These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

112 related articles for article (PubMed ID: 12385860)

  • 1. Dydrogesterone does not reverse the effects of estradiol on endothelium-dependant vasodilation in postmenopausal women: a randomised clinical trial.
    Gambacciani M; Monteleone P; Vitale C; Silvestri A; Fini M; Genazzani AR; Rosano GM
    Maturitas; 2002 Oct; 43(2):117-23. PubMed ID: 12385860
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Effect of estradiol valerate alone or in association with cyproterone acetate upon vascular function of postmenopausal women at increased risk for cardiovascular disease.
    Vitale C; Fini M; Leonardo F; Rossini P; Cerquetani E; Onorati D; Rosano GM
    Maturitas; 2001 Dec; 40(3):239-45. PubMed ID: 11731185
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Randomized, double-blind, placebo-controlled study on effects of raloxifene and hormone replacement therapy on plasma no concentrations, endothelin-1 levels, and endothelium-dependent vasodilation in postmenopausal women.
    Saitta A; Altavilla D; Cucinotta D; Morabito N; Frisina N; Corrado F; D'Anna R; Lasco A; Squadrito G; Gaudio A; Cancellieri F; Arcoraci V; Squadrito F
    Arterioscler Thromb Vasc Biol; 2001 Sep; 21(9):1512-9. PubMed ID: 11557681
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Estradiol therapy combined with progesterone and endothelium-dependent vasodilation in postmenopausal women.
    Gerhard M; Walsh BW; Tawakol A; Haley EA; Creager SJ; Seely EW; Ganz P; Creager MA
    Circulation; 1998 Sep; 98(12):1158-63. PubMed ID: 9743505
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Effect of medroxyprogesterone acetate plus estradiol on endothelium-dependent vasodilation in postmenopausal women.
    Kawano H; Motoyama T; Hirai N; Yoshimura T; Kugiyama K; Ogawa H; Okamura H; Yasue H
    Am J Cardiol; 2001 Jan; 87(2):238-40, A9. PubMed ID: 11152852
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Different effect of hormone replacement therapy, DHEAS and tibolone on endothelial function in postmenopausal women with increased cardiovascular risk.
    Silvestri A; Gambacciani M; Vitale C; Monteleone P; Ciaponi M; Fini M; Genazzani AR; Mercuro G; Rosano GM
    Maturitas; 2005 Apr; 50(4):305-11. PubMed ID: 15780531
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The effect of the phytoestrogen genistein on plasma nitric oxide concentrations, endothelin-1 levels and endothelium dependent vasodilation in postmenopausal women.
    Squadrito F; Altavilla D; Morabito N; Crisafulli A; D'Anna R; Corrado F; Ruggeri P; Campo GM; Calapai G; Caputi AP; Squadrito G
    Atherosclerosis; 2002 Aug; 163(2):339-47. PubMed ID: 12052481
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Effects of 15 months of 17 beta-estradiol and dydrogesterone on systolic cardiac function according to quantitative and Doppler echocardiography in healthy postmenopausal women.
    Kessel H; Kamp O; Kenemans P; Mijatovic V; van Baal WM; Visser CA; van der Mooren MJ
    Am J Obstet Gynecol; 2001 Apr; 184(5):910-6. PubMed ID: 11303198
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Effect of genistein on endothelial function in postmenopausal women: a randomized, double-blind, controlled study.
    Squadrito F; Altavilla D; Crisafulli A; Saitta A; Cucinotta D; Morabito N; D'Anna R; Corrado F; Ruggeri P; Frisina N; Squadrito G
    Am J Med; 2003 Apr; 114(6):470-6. PubMed ID: 12727580
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Estrogen improves endothelium-dependent, flow-mediated vasodilation in postmenopausal women.
    Lieberman EH; Gerhard MD; Uehata A; Walsh BW; Selwyn AP; Ganz P; Yeung AC; Creager MA
    Ann Intern Med; 1994 Dec; 121(12):936-41. PubMed ID: 7978718
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Effect of hormone replacement therapy on plasma lipoproteins and apolipoproteins, endothelial function and myocardial perfusion in postmenopausal women with estrogen receptor-alpha IVS1-397 C/C genotype and established coronary artery disease.
    Emre A; Sahin S; Erzik C; Nurkalem Z; Oz D; Cirakoglu B; Yesilcimen K; Ersek B
    Cardiology; 2006; 106(1):44-50. PubMed ID: 16612068
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Effects of raloxifene on endothelium-dependent dilation, lipoproteins, and markers of vascular function in postmenopausal women with coronary artery disease.
    Griffiths KA; Sader MA; Skilton MR; Harmer JA; Celermajer DS
    J Am Coll Cardiol; 2003 Aug; 42(4):698-704. PubMed ID: 12932604
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Lipid effects of hormone replacement therapy with sequential transdermal 17-beta-estradiol and oral dydrogesterone.
    Nieto JJ; Cogswell D; Jesinger D; Hardiman P
    Obstet Gynecol; 2000 Jan; 95(1):111-4. PubMed ID: 10636512
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Hormone replacement therapy with 17 beta-estradiol dydrogesterone: results of a 3-month open-label study].
    Grisar J; Travica S; Metka M; Pietschmann P
    Wien Klin Wochenschr; 1999 Dec; 111(24):1035-43. PubMed ID: 10677891
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Effect of postmenopausal oestradiol and dydrogesterone therapy on lipoproteins and insulin sensitivity, secretion and elimination in hysterectomised women.
    Manassiev NA; Godsland IF; Crook D; Proudler AJ; Whitehead MI; Stevenson JC
    Maturitas; 2002 Jul; 42(3):233-42. PubMed ID: 12161048
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Acute vascular effects of estrogen in postmenopausal women.
    Gilligan DM; Badar DM; Panza JA; Quyyumi AA; Cannon RO
    Circulation; 1994 Aug; 90(2):786-91. PubMed ID: 8044949
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Estradiol and dydrogesterone. A review of their combined use as hormone replacement therapy in postmenopausal women.
    Foster RH; Balfour JA
    Drugs Aging; 1997 Oct; 11(4):309-32. PubMed ID: 9342560
    [TBL] [Abstract][Full Text] [Related]  

  • 18. 17beta-estradiol (1 mg/day) continuously combined with dydrogesterone (5, 10 or 20 mg/day) increases bone mineral density in postmenopausal women.
    Stevenson JC; Teter P; Lees B
    Maturitas; 2001 Apr; 38(2):197-203. PubMed ID: 11306209
    [TBL] [Abstract][Full Text] [Related]  

  • 19. 1 and 2 mg 17beta-estradiol combined with sequential dydrogesterone have similar effects on the serum lipid profile of postmenopausal women.
    Stevenson JC; Rioux JE; Komer L; Gelfand M
    Climacteric; 2005 Dec; 8(4):352-9. PubMed ID: 16390770
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Long-term effects of combined hormone replacement therapy on markers of endothelial function and inflammatory activity in healthy postmenopausal women.
    van Baal WM; Kenemans P; Emeis JJ; Schalkwijk CG; Mijatovic V; van der Mooren MJ; Vischer UM; Stehouwer CD
    Fertil Steril; 1999 Apr; 71(4):663-70. PubMed ID: 10202876
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.